Chenyang Zhang

Analysis of Therapeutic Targets of A Novel Peptide Athycaltide-1 in the Treatment of Isoproterenol-Induced Pathological Myocardial Hypertrophy

Liying Hao, Jingyuan Li, Xi Zheng, 2022, Cardiovascular therapeutics.

Dusp6 deficiency attenuates neutrophil-mediated cardiac damage in the acute inflammatory phase of myocardial infarction

Shengshou Hu, Zhengfan Jiang, Xiaojun Zhu, 2022, Nature Communications.

The novel peptide athycaltide-1 attenuates Ang II-induced pathological myocardial hypertrophy by reducing ROS and inhibiting the activation of CaMKII and ERK1/2.

Wei Li, Ming Lei, Liying Hao, 2023, European journal of pharmacology.